India's first nationwide mapping of dengue virus strains has found all four dengue serotypes circulating simultaneously ...

India has approved its first dengue vaccine, Qdenga, for individuals aged 4 to 60, offering a two-dose defence against all ...

India's first dengue virus mapping shows all four serotypes circulating in eight states. This finding could influence the ...

India has approved its first dengue vaccine, QDENGA, for people aged 4 to 60 years. Know who can receive it, how the two-dose ...

In a phase 3 clinical trial, the tetravalent dengue vaccine, developed by the Butantan Institute in São Paulo, Brazil, was 80.5% effective against severe dengue cases with warning signs over a ...

CDSCO has cleared Takeda's QDENGA dengue vaccine for people aged 4–60 years, marking a major milestone as India steps up its ...

India faces heightened dengue risks as multiple virus strains co-circulate, complicating future vaccination efforts, a new ...

India has approved its first dengue vaccine as cases of the mosquito-borne disease surge in South Asia. Japan's Takeda ...

Monsoon often brings relief from the heat, but it also marks the return of one of India's biggest seasonal health concerns: ...

Qdenga could be responsible for enhancing dengue in children who have not had an infection yet in their lives. In such cases, ...

India has approved Takeda's QDENGA, the country's first dengue vaccine. The shot protects against all four dengue virus ...

India approves QDENGA, its first dengue vaccine. This milestone is only the start of a larger public health challenge.